ANAPC1, a neurodevelopmental facilitator, and MERTK, a TAM receptor and multiple sclerosis risk gene, have also been proposed as candidate genes for the psychosis phenotype of 2q13 CNV carriers (Costain et al., 2013). Here, MERTK is linked to multiple sclerosis.